There is no denying that Vietnam truly is an attractive investment destination in South East Asia. It has great potential to develop a qualitative, self-sustaining life science sector.

On 3 January 2011, Vietnam’s Ministry of Industry and Trade (MOIT) issued Circular No. 02/0211/TT-BCT (Circular 02) guiding the implementation of Decree No. 119/2007/ND-CP dated 18 July 2007 (Decree 119) on the manufacturing and trading of tobacco.

There is no denying that Vietnam truly is an attractive investment destination in South East Asia.

Vietnam's response to COVID-19 is a perfect example of how a country with modest financial means can successfully address a grave health challenge. At the end of Vietnam's first pandemic...

Vietnam's Ministry of Health has issued Circular No. 32/2026/TT-BYT, introducing significant reforms to the drug registration process that will take effect on October 1, 2026. The new regulations establish a five-year data exclusivity period for new drugs, simplify requirements for foreign legal documents, and introduce a re-examination pathway that could reduce administrative burdens for pharmaceutical companies.

Decree 38 provides a better scope defining to which entities it applies.It also introduces several more severe penalities for violations related to advertising for certain products...

Laut einer neu verabschiedeten Regelung in Jakarta, benötigt jedes nicht in Indonesien hergestellte Medikament eine zwingende Lizenz. Während für wirtschaftliche ...

On November 8, 2021, the Vietnamese government issued Decree No. 98/2021/ND-CP on the Management of Medical Devices ("Decree 98").

Nick Redfearn discusses Pharma-related counterfeiting in SEA in the Law, Lore & Practice, PTMG December 2022 edition...

After Brexit the UK negotiated an FTA with the Vietnamese government to be able to enjoy similiar or better trade conditions as it would have had under the EVFTA. In this update you can read some notable points.

Recent updates on legal legislation in November.

On June 29, 2025, the government of Vietnam issued Decree No. 163/2025/ND-CP providing detailed guidance on the implementation of the amended Law on Pharmacy (Decree 163).

Vietnam's biodiversity represents an underappreciated investment opportunity in biotechnology, pharmaceuticals, and agricultural innovation. The country's Law on Biodiversity creates a structured legal framework...

A. Überblick über die Zukunft des vietnamesischen Gesundheitssektors

Artificial Intelligence ("AI") is, perhaps, the fastest growing and most impactful technology today.

Der vietnamesische Pharmamarkt gehört zu den am schnellsten wachsenden in Asien. Mit einer Bevölkerung von über 100 Millionen, steigenden Gesundheitsausgaben...

Vietnam hat sich fest als eines der attraktivsten Investitionsziele in Südostasien etabliert.

Understanding Vietnamese laws and regulations concerning food can be a challenge. The government relies on general laws to regulate the quality of goods, including food.

What are the three central/federal government entities that have conducted the largest procurements by volume in Vietnam in the last three years?

Vietnam has firmly established itself as one of the most attractive investment destinations in Southeast Asia.